Corteva, Inc. (NYSE:CTVA – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twenty-two research firms that are currently covering the firm, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold recommendation, thirteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $82.90.
A number of equities research analysts have issued reports on the stock. UBS Group lowered shares of Corteva from a “buy” rating to a “hold” rating in a report on Monday, February 9th. Argus upgraded shares of Corteva to a “strong-buy” rating in a research report on Friday, January 16th. BNP Paribas Exane raised their target price on shares of Corteva from $72.00 to $74.00 in a research note on Monday, March 9th. Wells Fargo & Company lifted their price target on shares of Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Finally, The Goldman Sachs Group reiterated a “buy” rating and issued a $88.00 price target on shares of Corteva in a research note on Thursday, February 5th.
Get Our Latest Stock Report on CTVA
Corteva Stock Performance
Corteva (NYSE:CTVA – Get Free Report) last issued its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter last year, the company earned $0.32 EPS. The firm’s quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts predict that Corteva will post 2.96 EPS for the current fiscal year.
Corteva Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date was Monday, March 2nd. Corteva’s payout ratio is currently 45.57%.
Insider Buying and Selling
In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.14% of the company’s stock.
Institutional Trading of Corteva
Several hedge funds have recently modified their holdings of the company. Chilton Capital Management LLC lifted its holdings in shares of Corteva by 18.1% in the 3rd quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock valued at $30,119,000 after acquiring an additional 68,380 shares during the last quarter. TriaGen Wealth Management LLC purchased a new position in Corteva in the third quarter worth about $4,284,000. Truist Financial Corp increased its stake in Corteva by 4.5% during the third quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock worth $21,771,000 after acquiring an additional 13,910 shares during the last quarter. New York State Teachers Retirement System raised its position in Corteva by 4.5% during the third quarter. New York State Teachers Retirement System now owns 551,389 shares of the company’s stock valued at $37,290,000 after purchasing an additional 23,548 shares during the period. Finally, Alberta Investment Management Corp purchased a new stake in Corteva during the third quarter valued at approximately $5,018,000. 81.54% of the stock is owned by hedge funds and other institutional investors.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Read More
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
